Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target Cut to $27.00 by Analysts at The Goldman Sachs Group
Day One Biopharmaceuticals (NASDAQ:DAWN – Free Report) had its price objective trimmed by The Goldman Sachs Group from $39.00 ...